OTC Markets EXMKT - Delayed Quote USD

Claritas Pharmaceuticals, Inc. (CLAZF)

0.0001
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2020
Total Revenue
0
0
Operating Expense
-485
-184
Operating Income
485
184
Net Non Operating Interest Income Expense
-2,977
-271
Other Income Expense
--
-587
Pretax Income
-3,079
-674
Tax Provision
-4,884
-4,884
Net Income Common Stockholders
-4,718
4,210
Diluted NI Available to Com Stockholders
-4,718
4,210
Basic EPS
-0.13
0.16
Diluted EPS
-0.13
0.16
Basic Average Shares
30,966.7170
26,691.1840
Diluted Average Shares
30,966.7170
26,691.1840
Total Operating Income as Reported
--
-3,276
Total Expenses
-485
-184
Net Income from Continuing & Discontinued Operation
-4,718
4,210
Normalized Income
2,233.5100
4,638.5100
Interest Expense
768
225
Net Interest Income
-2,977
-271
EBIT
-2,311
-449
EBITDA
-2,311
-449
Net Income from Continuing Operation Net Minority Interest
1,805
4,210
Total Unusual Items Excluding Goodwill
-587
-587
Total Unusual Items
-587
-587
Normalized EBITDA
-1,724
138
Tax Rate for Calcs
0.0003
0.0003
Tax Effect of Unusual Items
-158.4900
-158.4900
12/31/2020 - 4/12/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers